GENE ONLINE|News &
Opinion
Blog

M&A
GeneOnline’s Top 10 M&As of 2021
2022-01-11
Quidel to Acquire Ortho Clinical for $6 billion to Diversify Diagnostics Portfolio
2021-12-24
Novartis Books Gyroscope for $1.5 Billion in Pursuit of Gene Therapy for Blindness
2021-12-23
Sanofi Bets $1 Billion on Preclinical Next-gen Immunotherapies
2021-12-22
Oracle Acquires Cerner to Expand Digital Healthcare Management Offerings
2021-12-21
Australia’s CSL Makes $11.7 Billion Bid for Swiss Drugmaker Vifor
2021-12-15
Pfizer to Acquire Arena and its Immuno-Inflammatory Drug for $6.7 Billion
2021-12-14
Thermo Fisher Bolsters Clinical Research Services with $17.4 Billion Acquisition of PPD
2021-12-10
How CDMOs are Restructuring the Biopharma Landscape – An Interview with Bobby Sheng
2021-12-06
Roche Gets Shareholders Nod to Repurchase $21B Equity Stake Held By Novartis
2021-11-27
Following Two Years of Promising RNAi Collab, Novo Nordisk Decides to Acquire Dicerna for $3.3 Billion
2021-11-18
Takeda Snags UK-Based Cell Therapy Collaborator to Boost Immuno-Oncology Portfolio
2021-10-27
M&A
Supernus Invests $400 Million to Acquire New Parkinson’s Assets from Adamas
2021-10-12
Pacira Acquires Flexion for $425 Million to Expand Non-Opioid Painkiller Portfolio
2021-10-12
Amicus Therapeutics Spins Off Its Gene Therapy Unit in a SPAC Deal
2021-10-02
1 5 6 7 8 9 14
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top